# Antimicrobial Susceptibility Testing Guided Antibiotic Selection Strategies in Salvage Helicobacter Pylori Treatment

> **NCT02988089** · PHASE4 · UNKNOWN · sponsor: **Shandong University** · enrollment: 480 (estimated)

## Conditions studied

- Helicobacter Pylori Infection
- Antimicrobial Susceptibility Testing

## Interventions

- **DRUG:** Clarithromycin susceptibility dependant strategy
- **DRUG:** 2 susceptible antibiotics (amoxicillin, clarithromycin, metronidazole, tinidazole,levofloxacin, furazolidone and tetracycline )
- **DRUG:** proton pump inhibitor (PPI) and Colloidal Bismuth Pectin
- **DRUG:** amoxicillin and clarithromycin or amoxicillin and furazolidone
- **DRUG:** amoxicillin and furazolidone or amoxicillin and tetracycline
- **DRUG:** amoxicillin and furazolidone or amoxicillin and Tinidazole or amoxicillin and Levofloxacin

## Key facts

- **NCT ID:** NCT02988089
- **Lead sponsor:** Shandong University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2017-04-20
- **Primary completion:** 2017-09
- **Final completion:** 2017-09
- **Target enrollment:** 480 (ESTIMATED)
- **Last updated:** 2017-04-25

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02988089

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02988089, "Antimicrobial Susceptibility Testing Guided Antibiotic Selection Strategies in Salvage Helicobacter Pylori Treatment". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02988089. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*